Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 267 participants.
Also called NCT04595968
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 267 participants
- Sponsor
- Registry
-
NCT04595968
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United States, Ireland
- Registry status
- Completed
Technical summary
Registry record NCT04595968. Randomized; triple masking; primary purpose treatment. Start 2021-05-21 (actual); primary completion 2024-08-06 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus
- Condition
- Type 2 Diabetes
- Intervention (Device)
- Vestal DM Active device
- Intervention (Behavioral)
- Lifestyle modification
- Intervention (Device)
- Vestal DM Sham device
- Lead sponsor
- Neurovalens Ltd.
- Collaborator
- University College Dublin
- Collaborator
- CS Lifescience
- Collaborator
- Clinical Trial Mentors
Record details
- Record id
cardio:ct-nct04595968- Content hash
2410735336708cfce1472713a93cf94b0257254f198b4d75fa14889ae823387f